
Rainbow Children's Medicare Q2 Results FY27: Profit Rises 10.94% as Revenue Hits Rs 548.02 Cr, PAT Rs 83.89 Cr
Updated: 31 Oct 2026 • 9:11 pm
Posted by:

Quick Answer
Rainbow Children's Medicare Q2 Results FY27 were declared on 31 October 2026 for the July to September 2026 quarter. Consolidated revenue rose 23.21% year on year to Rs 548.02 Cr, while net profit rose 10.94% to Rs 83.89 Cr. These quarterly results show YoY growth in every line, with Operating Profit at Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr.
Rainbow Children's Medicare Ltd (RAINBOW) Q2 Results FY27 announced on 31 October 2026, covering the company's financial performance for the July to September quarter. Rainbow Children's Medicare Q2 Results FY27 carry a results date of 31 October 2026 and present consolidated results, with revenue of Rs 548.02 Cr and net profit (PAT) of Rs 83.89 Cr.
This results analysis of Rainbow Children's Medicare Q2 Results covers the financial highlights, business factors, outlook and risks for the quarter. It starts with the Financial Highlights table that sets out revenue, Operating Profit and net profit against the same quarter last year.
Click Here – Get Free Investment Predictions
Rainbow Children's Medicare Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 548.02 Cr | Rs 444.8 Cr | +23.21% YoY |
| Operating Profit | Rs 169.98 Cr | Rs 148.86 Cr | +14.19% YoY |
| Net Profit (PAT) | Rs 83.89 Cr | Rs 75.62 Cr | +10.94% YoY |
Source: company filing for Rainbow Children's Medicare Q2 Results FY27, 31 October 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Rainbow Children's Medicare Q2 Results: What Stands Out
- Revenue: Revenue rose 23.21% year on year to Rs 548.02 Cr from Rs 444.80 Cr in the same quarter last year.
- Net profit: Net profit (PAT) rose 10.94% to Rs 83.89 Cr from Rs 75.62 Cr, a slower pace than the revenue line.
- Operating Profit: Operating Profit reached Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr, sitting between revenue and net profit growth.
- Margin watch: Net profit margin narrowed to 15.3% from 17.0% in the comparison quarter, the main risk headline for this filing.
- Next step: Positive YoY growth in all three lines sets up the Rainbow Children's Medicare Q2 Results FY27 performance analysis that follows.
Rainbow Children's Medicare Q2 Results FY27: Performance Analysis
The performance analysis shows that Rainbow Children's Medicare Q2 Results FY27 delivered consolidated revenue of Rs 548.02 Cr, up 23.21% from Rs 444.80 Cr a year earlier. Operating Profit grew 14.19% to Rs 169.98 Cr and net profit grew 10.94% to Rs 83.89 Cr, so the quarterly results show higher figures across all three lines.
Growth was strongest at the revenue line at 23.21%, followed by Operating Profit at 14.19% and net profit at 10.94%. This ordering means the Rainbow Children's Medicare Q2 Results results analysis points to a smaller share of each rupee of sales reaching profit than a year earlier, with net profit margin at 15.3% against 17.0%.
Revenue has also risen in each of the last 4 quarters, a pattern investors can track in the next filing. The consolidated figures for July to September 2026 now form the base for Rainbow Children's Medicare Q2 Results FY27 comparisons, and the business factors behind these numbers come next.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The business factors begin with revenue, which grew 23.2% year on year to Rs 548.02 Cr in the latest quarter. These quarterly results show the top line moving ahead of both profit lines reported with Rainbow Children's Medicare Q2 Results FY27.
Consecutive Quarterly Gains – Revenue has risen in each of the last 4 quarters, so the Rs 548.02 Cr reported this time extends a run of consecutive increases. The figures confirm the run but do not establish the specific cause.
Return on Equity – Return on equity was 18.10% in FY26. Net profit also rose 10.9% year on year to Rs 83.89 Cr this quarter, so the longer profitability measure and the latest earnings can be read side by side.
FY27 Outlook After Rainbow Children's Medicare Q2 Results
FY27 full-year results will depend on the quarters that follow and on disclosed sector conditions. Net profit of Rs 83.89 Cr and Operating Profit of Rs 169.98 Cr give a reference point for those later comparisons, and revenue of Rs 548.02 Cr sets the quarterly base.
Readers following this results analysis can use the Univest Screener and the Univest app to compare later filings after Rainbow Children's Medicare Q2 Results FY27 against the next quarter's net profit and revenue. The next set of figures will show whether the margin move persists, which brings the discussion to the risks.
Key Risks to Watch After Rainbow Children's Medicare Q2 Results FY27
Narrower Net Profit Margin
Net profit margin narrowed to 15.3% from 17.0% in the comparison quarter. The YoY growth in net profit of 10.94% trailed revenue growth of 23.21%, which makes the margin the first figure to watch in the next filing.
Lower Return on Capital Employed
Return on capital employed declined to 28.25% in FY26 from 29.83% in FY25. Investors tracking Rainbow Children's Medicare Q2 Results FY27 may want to see whether the ratio holds in later disclosures as the company reports further quarters.
Profit Growing Slower Than Sales
Net profit grew 10.9% against revenue growth of 23.2%, so less of each rupee of sales reached the bottom line. The gap between the two growth rates is a measurable item to compare quarter by quarter.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Rainbow Children's Medicare Q2 Results FY27 record revenue of Rs 548.02 Cr and net profit of Rs 83.89 Cr, both higher year on year. These consolidated results and the other quarterly results figures in this article are best read with the margin data alongside. For Rainbow Children's Medicare Q2 Results readers, consulting a SEBI-registered advisor before acting on any figure is advisable.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Rainbow Children's Medicare Q2 Results FY27
What are Rainbow Children's Medicare Q2 Results FY27?
Ans. Rainbow Children's Medicare Q2 Results FY27 cover the July to September 2026 quarter on a consolidated basis. Alongside this, revenue came in at Rs 548.02 Cr and net profit at Rs 83.89 Cr, as the Quick Answer shows.
What is the results date for Rainbow Children's Medicare Q2 Results FY27?
Ans. The results date for Rainbow Children's Medicare Q2 Results FY27 is 31 October 2026, covering the July to September 2026 quarter. This matches the opening section, which also states the consolidated results basis used for every figure.
What revenue was reported in Rainbow Children's Medicare Q2 Results FY27?
Ans. Rainbow Children's Medicare reported Q2 FY27 consolidated revenue of Rs 548.02 Cr, compared with Rs 444.80 Cr a year earlier. That comparison sits in the Financial Highlights table and drives the Performance Analysis section.
What net profit was reported in Rainbow Children's Medicare Q2 Results FY27?
Ans. Rainbow Children's Medicare reported Q2 FY27 net profit of Rs 83.89 Cr against Rs 75.62 Cr a year earlier. This net profit appears in the Financial Highlights table, while the Performance Analysis compares it with revenue.
How much YoY growth did revenue show in Rainbow Children's Medicare Q2 Results FY27?
Ans. Revenue showed YoY growth of 23.21% in Rainbow Children's Medicare Q2 Results FY27, moving from Rs 444.80 Cr to Rs 548.02 Cr. This is the fastest of the three growth rates, as the Performance Analysis section explains.
Did net profit rise or fall in Rainbow Children's Medicare Q2 Results?
Ans. Net profit rose in Rainbow Children's Medicare Q2 Results, up 10.94% from Rs 75.62 Cr to Rs 83.89 Cr. That rise was slower than the 23.21% revenue growth, so the Key Takeaways section highlights the gap.
What was the Operating Profit in Rainbow Children's Medicare Q2 Results FY27?
Ans. Operating Profit in Rainbow Children's Medicare Q2 Results FY27 was Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr a year earlier. This places it between revenue growth and net profit growth, as the Key Takeaways section notes.
Are Rainbow Children's Medicare Q2 Results consolidated results or standalone results?
Ans. Rainbow Children's Medicare Q2 Results are consolidated results, so the figures reflect the group rather than a single entity. The opening section and the Financial Highlights table both apply this consolidated basis to every metric.
What business factors shaped Rainbow Children's Medicare Q2 Results FY27?
Ans. Revenue growth of 23.2% year on year, four straight quarters of rising revenue and return on equity of 18.10% in FY26 shaped Rainbow Children's Medicare Q2 Results FY27. The Key Business Factors section lists each of them.
What are the key risks after Rainbow Children's Medicare Q2 Results FY27?
Ans. After Rainbow Children's Medicare Q2 Results FY27, the risks are a net profit margin of 15.3% against 17.0%, return on capital employed of 28.25% against 29.83%, and profit growing slower than sales. The Key Risks section covers each.
What is the outlook after Rainbow Children's Medicare Q2 Results?
Ans. The FY27 outlook after Rainbow Children's Medicare Q2 Results depends on later quarters and disclosed sector conditions. The Outlook section treats net profit of Rs 83.89 Cr and revenue of Rs 548.02 Cr as the reference base.
Where can I find the complete Rainbow Children's Medicare Q2 Results FY27 data?
Ans. The complete Rainbow Children's Medicare Q2 Results FY27 data is in the Financial Highlights table above, with revenue, Operating Profit and net profit for both periods. Readers can use the Univest Screener alongside it to compare future quarters.
Recent Articles

Muthoot Finance Q2 Results FY27: PAT Jumps 35.92% to Rs 3,278.00 Cr, Revenue Rs 9,997.77 Cr
31 October 2026

T.T Q2 Results FY27: PAT Rises 33.33% to Rs 0.24 Cr, Revenue Rs 48.37 Cr
31 October 2026

Mahalaxmi Rubtech Q2 Results FY27: PAT Dips 5.61% to Rs 5.55 Cr, Revenue Rs 33.44 Cr
31 October 2026

STUDDS ACCESSORIES Q2 Results FY27: PAT Falls 28.52% to Rs 14.74 Cr, Revenue Rs 183.11 Cr
31 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Muthoot Finance Q2 Results FY27: PAT Jumps 35.92% to Rs 3,278.00 Cr, Revenue Rs 9,997.77 Cr
T.T Q2 Results FY27: PAT Rises 33.33% to Rs 0.24 Cr, Revenue Rs 48.37 Cr
Mahalaxmi Rubtech Q2 Results FY27: PAT Dips 5.61% to Rs 5.55 Cr, Revenue Rs 33.44 Cr
STUDDS ACCESSORIES Q2 Results FY27: PAT Falls 28.52% to Rs 14.74 Cr, Revenue Rs 183.11 Cr
Mrugesh Trading Q2 Results FY27: Returns to Profit, Revenue Rs 1.71 Cr, PAT Rs 0.14 Cr
Popular this week
Neogen Chemicals Q2 Results FY27: PAT Jumps 144.21% to Rs 8.23 Cr, Revenue Rs 295.96 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





